By using tetraethyl ortho silicate (TEOS) as the anchoring unit for SiQAC and other organofunctional trialkoxysilanes (e.g. vinyl, epoxy, isocynate or methacryloxy functionalities) in a mix-and-match approach different end-functional macro monomers may be synthesized with permanent, non leaching microbiocidal activities that are independent of the loss of the surface layer, as the activity has been incorporated throughout the product.
Material Property Enhancements
Non-leaching antibacterial, antiviral antifungal
Adhesive composition supports self-promoting adhesion to a wide variety of substrates
Emulsifier allows previously non-miscible materials to coexist in synergistically react
Plasticizer compatible in a variety of chemical systems (acrylates, epoxies, polymers, elastomers)
Surface property modifier provides control surface energy properties.
Facile modifications of surface hydrophobicity or hydrophilicity — (system dependent, user-defined).
Enhanced wettability and bondability onto a wide variety of substrates: carbon fibers, glass fibers, etc
Controlled enhancement a filler/binder
Promotes covalent bonding between wide variety of filler particles and surrounding networks
— (organic or inorganic)
Bonds to silica, kaolin, aluminum trihydrate, titanium dioxide, etc.
Can be used to create its own controlled-sized in-situ filler — (silsesquioxanes and ormosiles)
As additive to thermoset/thermoplastic resins
Increase polymer conversion
Decrease polymerization shrinkage
As additive to Elastomer-Rubber
Easily incorporated into resins master-batch, extruded/blown films or spray for coatings and nonwovens
Broad industrial and consumer product applications
Reduces process waste eluents to improve environmental conditions
Lessens environmental impact of many current products/systems
Reduces environmental bisphenol A and phthalates
Reduces usage of surface disinfectants
Product process systems unlimited
Biopositive: MMP and Cathepsin Inhibitors
Endless applications in the health-care field, resulting in saving millions of lives and billions in healthcare costs
510K Clearance on fiteBac QAMS and lead molecule K21 in New Drug Application 128706